av/inventiva--big.svg

COM:INVENTIVAPHARMA

Inventiva Pharma

  • Stock

Last Close

2.58

21/11 16:35

Market Cap

125.95M

Beta: -

Volume Today

19.73K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
3.06M
-
3.28M
7.13%
4.87M
48.49%
9.45M
93.77%
6.52M
30.96%
3.20M
50.97%
7.00M
118.89%
372K
94.68%
4.19M
1,027.42%
12.18M
190.39%
17.50M
43.69%
cost of revenue
1.68M
-
1.52M
9.42%
1.40M
7.79%
1.49M
5.78%
1.24M
16.83%
967K
21.76%
846K
-
gross profit
1.38M
-
1.76M
27.26%
3.47M
97.22%
7.96M
129.40%
5.28M
33.60%
2.23M
57.80%
7.00M
213.81%
-474K
106.77%
4.19M
984.81%
12.18M
190.39%
17.50M
43.69%
selling and marketing expenses
325.57K
-
247.31K
24.04%
112.70K
54.43%
50.56K
55.14%
37.78K
25.27%
9K
76.18%
8K
11.11%
563K
6,937.50%
364K
35.35%
2.58M
609.62%
general and administrative expenses
2.71M
-
2.65M
2.13%
3.11M
17.30%
3.25M
4.34%
4.09M
25.91%
4.51M
10.40%
4.51M
0.13%
8.50M
88.62%
11.16M
31.26%
12.91M
15.74%
selling general and administrative expenses
3.04M
-
2.90M
4.48%
3.22M
11.19%
3.30M
2.26%
4.12M
25.13%
4.52M
9.61%
4.51M
0.15%
9.06M
100.75%
11.52M
27.12%
15.49M
34.51%
research and development expenses
13.75M
-
16.28M
18.45%
19.64M
20.61%
22.14M
12.76%
26.73M
20.72%
31.64M
18.34%
33.79M
6.81%
23.72M
29.81%
48.45M
104.29%
60.47M
24.80%
other expenses
257K
-
-2.09M
914.01%
-2.69M
28.54%
-3.66M
36.22%
-6.67M
82.23%
cost and expenses
15.53M
-
16.75M
7.85%
19.75M
17.91%
21.49M
8.84%
26.99M
25.55%
36.41M
34.93%
36.21M
0.55%
30.09M
16.91%
56.31M
87.14%
69.29M
23.05%
operating expenses
15.53M
-
16.75M
7.85%
19.75M
17.91%
21.49M
8.84%
26.99M
25.55%
36.41M
34.93%
36.21M
0.55%
30.09M
16.91%
56.31M
87.14%
69.29M
23.05%
interest expense
630
-
2.94K
366.19%
6.06K
106.37%
7.55K
24.53%
5.32K
29.57%
4K
24.76%
3K
25%
66K
2,100%
2.63M
3,892.42%
707K
73.17%
ebitda
-10.34M
-
-11.47M
10.93%
-13.08M
14.07%
-9.90M
24.30%
-18.77M
89.49%
-31.00M
65.15%
-27.50M
11.29%
-29.72M
8.09%
-46.64M
56.93%
-57.11M
22.46%
17.50M
130.64%
operating income
-12.47M
-
-13.47M
8.02%
-15.51M
15.17%
-13.02M
16.06%
-20.92M
60.66%
-33.25M
58.98%
-30.31M
8.84%
-29.72M
1.96%
-52.11M
75.36%
-57.11M
9.59%
17.50M
130.64%
depreciation and amortization
1.38M
-
1.23M
11.14%
1.30M
5.94%
1.65M
26.67%
1.42M
13.71%
2.26M
58.76%
2.82M
24.76%
1.89M
32.98%
5.48M
190.10%
1.70M
69.00%
total other income expenses net
4.23K
-
-21.30K
603.71%
-633.52K
2,873.98%
-998.47K
57.61%
-441.91K
55.74%
-110K
75.11%
95K
186.36%
-3.90M
4,207.37%
2.84M
172.83%
2.82M
0.91%
income before tax
-11.72M
-
-12.72M
8.56%
-15.02M
18.09%
-12.56M
16.41%
-20.64M
64.33%
-33.36M
61.66%
-30.22M
9.43%
-33.62M
11.26%
-49.27M
46.56%
-54.29M
10.19%
income tax expense
-4.58M
-
-5.23M
14.07%
-6.20M
18.59%
-5.51M
11.08%
-3.41M
38.18%
253K
107.42%
4K
98.42%
-2.00M
50,025%
364K
118.23%
-20K
105.49%
net income
-7.13M
-
-7.49M
5.03%
-8.82M
17.74%
-7.05M
20.15%
-17.23M
144.56%
-33.62M
95.11%
-30.22M
10.10%
-31.62M
4.64%
-49.64M
56.96%
-54.27M
9.34%
weighted average shs out
10.03M
-
10.03M
0%
10.03M
0.03%
15.68M
56.40%
15.52M
1.05%
20.54M
32.38%
23.52M
14.50%
33.87M
44.03%
39.17M
15.63%
41.45M
5.83%
weighted average shs out dil
10.03M
-
10.03M
0%
10.03M
0%
15.74M
56.90%
15.52M
1.40%
20.54M
32.38%
23.52M
14.50%
33.87M
44.03%
39.17M
15.63%
41.45M
5.83%
eps
-0.71
-
-0.75
5.63%
-0.88
17.33%
-0.45
48.86%
-1.11
146.67%
-1.64
47.75%
-1.28
21.95%
-0.93
27.34%
-1.27
36.56%
-1.31
3.15%
0
100%
epsdiluted
-0.71
-
-0.75
5.63%
-0.88
17.33%
-0.45
48.86%
-1.11
146.67%
-1.64
47.75%
-1.28
21.95%
-0.93
27.34%
-1.27
36.56%
-1.31
3.15%
0
100%

All numbers in (except ratios and percentages)